@article{d8d56b890a1341e68d3f475bac32655f,
title = "Editorial introductions",
author = "Hiess, {Manuela P.} and Vitaly Margulis and Hakimi, {A. Ari}",
note = "Funding Information: A. Ari Hakimi is an assistant attending in the Department of Surgery, Urology Service and member of the Immunogenomic and Precision Oncology Platform at Memorial Sloan Kettering Can- cer Center (MSKCC), New York, USA, where he leads the efforts in renal cell carcinoma. He co- directs the MSKCC Translational Kidney Cancer Working Group and has received or currently receives funding from the American Urologic Association, the Ludwig Institute, the Parker Institute for Cancer Immunotherapy, and the Department of Defense.",
year = "2019",
month = sep,
day = "1",
doi = "10.1097/MOU.0000000000000667",
language = "English (US)",
volume = "29",
pages = "V",
journal = "Current Opinion in Urology",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",
number = "5",
}